These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38899714)

  • 21. Diabetic cardiovascular disease lost in translation between endocrinology and cardiology.
    Dagdelen S
    Am J Cardiol; 2008 Oct; 102(8):1115-6. PubMed ID: 18929722
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
    Bethel MA; Califf RM
    Am J Cardiol; 2007 Mar; 99(5):726-31. PubMed ID: 17317381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].
    Karpov IuA; Shubina AT
    Kardiologiia; 2007; 47(10):90-5. PubMed ID: 18260953
    [No Abstract]   [Full Text] [Related]  

  • 24. SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?
    Wilding J
    Lancet Diabetes Endocrinol; 2016 May; 4(5):379-81. PubMed ID: 27009624
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.
    Saxon DR; Rasouli N; Eckel RH
    Drugs; 2018 Feb; 78(2):203-214. PubMed ID: 29305768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What has changed in the management of diabetes: medication and hygienic living].
    Rev Infirm; 2000 Apr; (59):23-4. PubMed ID: 11075168
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment Lowering of cardiovascular risk in treatment with liraglutide - Results of the LEADER].
    Olšovský J
    Vnitr Lek; 2016; 62(7-8):613-5. PubMed ID: 27627086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk and prevention in diabetes mellitus.
    Roberts AW
    Clin Med (Lond); 2010 Oct; 10(5):495-9. PubMed ID: 21117387
    [No Abstract]   [Full Text] [Related]  

  • 29. How to use type 2 diabetes meds to lower CV disease risk.
    Gotfried R
    J Fam Pract; 2019 Nov; 68(9):494;498;500;504. PubMed ID: 31725134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
    Szymborska-Kajanek A; Strojek K
    Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 32. Implications of cardiovascular outcome trials with injectable antidiabetic agents.
    Pratley RE
    J Diabetes; 2018 Oct; 10(10):801-803. PubMed ID: 29971941
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular diseases and diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006; 19(6):369-75. PubMed ID: 16971974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of thiazolidinedione from the cardiologic viewpoint].
    Ziegler R
    Med Monatsschr Pharm; 2005 Oct; 28(10):365. PubMed ID: 16245456
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
    Goodarzi MO; Psaty BM
    JAMA; 2008 Nov; 300(17):2051-3. PubMed ID: 18984894
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus : management strategies.
    Soedamah-Muthu SS; Stehouwer CD
    Treat Endocrinol; 2005; 4(2):75-86. PubMed ID: 15783245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of some antidiabetic drugs.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745
    [No Abstract]   [Full Text] [Related]  

  • 38. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 39. A report from the 72nd Scientific Sessions of the American Diabetes Association (June 8-12, 2012 - Philadelphia, Pennsylvania, USA).
    Rabasseda X
    Drugs Today (Barc); 2012 Aug; 48(8):555-72. PubMed ID: 22916343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes Management Update: Individualizing Treatment.
    Reid T
    J Fam Pract; 2019 Oct; 68(8):S13-S19. PubMed ID: 31697797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.